BlackBoxRX
 
We highly recommend enabling Javascript while using the BlackBoxRX site.

Blinatumomab

Cytokine Release Syndrome and Neurological Toxicities

  • Cytokine Release Syndrome (CRS), which may be life-threatening or fatal, occurred in patients receiving BLINCYTO. Interrupt or discontinue BLINCYTO as recommended.[See Dosage and Administration (2.3), Warnings and Precautions (5.1)].
  • Neurological toxicities, which may be severe, life-threatening, or fatal, occurred in patientsĀ receiving BLINCYTO. Interrupt or discontinue BLINCYTO as recommended. [SeeĀ Dosage and Administration (2.3), Warnings and Precautions (5.2)

Approved Risk Evaluation and Mitigation Strategies (REMS)

Blincyto (blinatumomab) Injection

Patient Counseling Information

Medication Guides

Patient Medication Guide

Package Inserts

Blinatumomab

Updated January 2018